Eric Shiozaki
Eric Shiozaki is a highly accomplished professional with an academic background in Biophysics and Molecular Biology.
He pursued his Bachelor of Arts in Biophysics from The Johns Hopkins University and further advanced his education by obtaining a Doctor of Philosophy in Molecular Biology from Princeton University.
Throughout his career, Eric has held key positions in prestigious organizations, showcasing his expertise and leadership skills.
Currently, he serves as a Partner at Dcvc Bio, where he contributes to strategic decision-making and business development.
Previously, Eric held Partner roles at Novo Ventures and also worked as a Principal at the same organization, demonstrating his extensive experience in venture capitalism.
His professional journey also includes a Director role at Apposite Capital, where he played a pivotal role in driving corporate development and strategy.
Before that, Eric served as a Corporate Development and Strategy Consultant at Vitapath Genetics, showcasing his versatility in the biotechnology industry.
His diverse experience further extends to roles such as an Associate at Burrill & Company, Technology Transfer Associate at UCLA, and Leukemia and Lymphoma Society Fellow at UCLA.
Eric's career trajectory reflects his commitment to the field of biophysics and molecular biology, with a strong focus on strategic roles within the biotechnology and venture capital sectors.
